deepc
Paul-Heyse-Strasse 27, München, Bayern, 80336, Germany
Overview
deepc is a Munich-based company that builds an AI operating system for radiologists and enterprise clinical organizations. Its flagship platform, deepcOS®, gives clinicians access to a marketplace of regulatory-approved AI solutions across more than 60 clinical indications, aiming to improve workflow efficiency and assist radiologists in routine tasks. The company provides installation, end-to-end integration, unified contracting and billing, and service under a comprehensive privacy and security framework. Led by CEO Dr. Franz Pfister, deepc plans to use recent funding to accelerate growth and international expansion and to further enhance and commercialize its operating system. Financially, deepc closed its Series A with a $13M extension that brought the Series A total to $30M. Investors on the extension included Sofinnova Partners and Bertelsmann Investments, with participation from KHP Ventures, SwissHealth Ventures and existing backer Winning Mindset Ventures. deepc develops deepcOS®, a cloud-native, vendor-neutral operating system that integrates third-party AI into existing radiology workflows. The platform allows approved AI vendors an efficient route to commercialize their solutions and offers hospitals and clinics a secure, one-stop shop for AI-assisted radiology. Led by co-founder and CEO Franz Pfister, deepc aims to give healthcare systems flexibility to adopt and integrate third-party AI technology while improving patient outcomes. The company plans to use the new funds to develop additional features and expand commercialization of deepcOS®. deepc is based in Munich, Germany. The company recently completed a significant financing to support product development and go-to-market expansion.
- Total raised
- $26M
- Funding rounds
- 2
- Latest round
- Series A
- Latest activity
- Jul 2024
Industries
- Artificial Intelligence (AI)
- Consulting
- Health Care
- Machine Learning
- Medical
- Medical Device
- Software
Recent funding
Series A
Jul 2024
$13M
Series A
Mar 2023
$13M